Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03761446 · ClinicalTrials.gov registry record · NA

The Role of Type 2 Diabetes on Skeletal Muscle Atrophy and Recovery Following Bed Rest in Older Adults

A NA study of Type 2 Diabetes and Aging, sponsored by AdventHealth Translational Research Institute.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT03761446 is a NA study of Type 2 Diabetes and Aging that is actively recruiting participants, run by AdventHealth Translational Research Institute. The registered enrollment target is 50 participants, below the 1,102-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03761446, a NA study of Type 2 Diabetes and Aging, is actively recruiting participants, sponsored by AdventHealth Translational Research Institute.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to determine the impact of pre-diabetes and type 2 diabetes on muscle atrophy during a period of bed rest and recovery of muscle mass, strength, and physical function following bed rest.

Interventions

  • BEHAVIORAL Bed rest

Study Locations (1)

Florida

  • Translational Research Institute for Metabolism and Diabetes - Orlando

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2019-03-18
Est. Completion 2025-12
Phase NA

What the Registry Record Tells You About NCT03761446

The ClinicalTrials.gov registry entry for NCT03761446 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,102-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (95% lower). The listed sponsor is AdventHealth Translational Research Institute, which has 54 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Type 2 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Bed rest is the first listed.

NCT03761446 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT03761446 about?

NCT03761446 is a clinical study titled "The Role of Type 2 Diabetes on Skeletal Muscle Atrophy and Recovery Following Bed Rest in Older Adults". The goal of this study is to determine the impact of pre-diabetes and type 2 diabetes on muscle atrophy during a period of bed rest and recovery of muscle mass, strength, and physical function following bed rest.

What is the current status of trial NCT03761446?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2019-03-18. Estimated completion is 2025-12.

What conditions does trial NCT03761446 study?

This clinical trial studies the following conditions: Type 2 Diabetes, Aging, Pre Diabetes, Sedentary Behavior, Muscle Atrophy.

What interventions are being tested in trial NCT03761446?

The interventions under investigation include: Bed rest (BEHAVIORAL).

Who is sponsoring clinical trial NCT03761446?

This trial is sponsored by AdventHealth Translational Research Institute, which has 54 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03761446 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 2 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.